Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis

Rheumatology International

Volumn 33, Issue 10, 2013, Pages 2637-2645

  Yildir, Seyfi ^a   Sezgin, Melek ^b   Barlas, Ibrahim Ömer ^b   Türköz, Gözde ^b   Ankarali, Handan Çamdeviren ^c   Şahin, Günşah ^b   Erdal, Mehmet Emin ^b  

^a MERSIN STATE HOSPITAL   (Turkey)

^b MERSIN UNIVERSITY   (Turkey)

^c DUZCE UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Fas; Fas ligand; Gene polymorphism; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; FAS ANTIGEN; FAS LIGAND; GENOMIC DNA; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY SCORE; DISEASE SEVERITY; DNA EXTRACTION; DNA POLYMORPHISM; ERYTHROCYTE SEDIMENTATION RATE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; PAIN ASSESSMENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VISUAL ANALOG SCALE;

ADULT; AGED; ALLELES; ANTIGENS, CD95; APOPTOSIS; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FAS LIGAND PROTEIN; FATIGUE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PAIN; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; TURKEY; VISUAL ANALOG SCALE;

EID: 84885383539     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2793-1     Document Type: Article

References (37)

1. Maini RN, Zvaifler NJ (1994) Rheumatoid arthritis and spondyloarthropathy. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, St Louis, pp 1-4
2. Sumida T, Hasunuma T, Asahara H, Maeda T, Nishioka K (1998) Rheumatoid arthritis and apoptosis. Intern Med 37:184-188
3. Wakisaka S, Suzuki N, Takeba Y, Shimoyama Y, Nagafuchi H, Takeno M, Saito N, Yokoe T, Kaneko A, Asai T, Sakane T (1998) Modulation by proinflammatory cytokines of Fas/Fas ligand-mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis (RA). Clin Exp Immunol 114:119-128
4. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462
5. Suda T, Takahashi T, Golstein P, Nagata S (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178
6. Wajant H (2002) The Fas signaling pathway: more than a paradigm. Science 296:1635-1636
7. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M et al (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243
8. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C et al (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 267:10709-10715
9. Okamoto K, Asahara H, Kobayashi T, Matsuno H, Hasunuma T, Kobata T et al (1998) Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer. Gene Ther 5:331-338
10. Pundt N, Peters MA, Wunrau C, Strietholt S, Fehrmann C, Neugebauer K et al (2009) Susceptibility of rheumatoid arthritis synovial fibroblasts to FasLand TRAIL-induced apoptosis is cell cycle-dependent. Arthritis Res Ther 11(1):R16
11. Nishioka K, Hasunuma T, Kato T, Sumida T, Kobata T (1998) Apoptosis in rheumatoid arthritis: a novel pathway in the regulation of synovial tissue. Arthritis Rheum 41:1-9
12. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K et al (1995) Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 38:485-491
13. Asahara H, Hasumuna T, Kobata T, Yagita H, Okumura K, Inoue H et al (1996) Expression of Fas antigen and Fas ligand in the rheumatoid synovial tissue. Clin Immunol Immunopathol 81:27-34
14. Firestein GS, Yeo M, Zvaifler NJ (1995) Apoptosis in rheumatoid arthritis synovium. J Clin Invest 96:1631-1638
15. Huang QR, Morris D, Manolios N (1997) Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol Immunol 34:577-582
16. Sibley K, Rollinson S, Allan JM, Smith AG, Law GR, Roddam PL et al (2003) Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res 63:4327-4330
17. Wu J, Metz C, Xu X, Abe R, Gibson AW, Edberg JC et al (2003) A novel polymorphic CAAT/enhancer-binding protein b element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. J Immunol 170:132-138
18. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay JP (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347-1349
19. Brunner T, Wasem C, Torgler R, Cima I, Jakob S, Corazza N (2003) Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology. Semin Immunol 15:167-176
20. Lee HO, Ferguson TA (2003) Biology of FasL. Cytokine Growth Factor Rev 14:325-335
21. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T et al (1994) Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol 6:1567-1574
22. Singh R, Pradhan V, Patwardhan M, Ghosh K (2009) APO-1/Fas gene: structural and functional characteristics in systemic lupus erythematosus and other autoimmune diseases. Indian J Hum Genet 153:98-102
23. Behrmann I, Walczak H, Krammer PH (1994) Structure of the human APO-1 gene. Eur J Immunol 12:3057-3062
24. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
25. Fuks A, Parton LA, Polavarapu S, Netta D, Strassberg S, Godi I et al (2005) Polymorphism of Fas and Fas ligand in preterm premature rupture of membranes in singleton pregnancies. Am J Obstet Gynecol 193:1132-1136
26. Aguilar-Reina J, Ruiz-Ferrer M, Pizarro MA, Antiñolo G (2005) The -670 A>G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis C. J Viral Hepat 12:568-573
27. Li C, Larson D, Zhang Z, Liu Z, Strom SS, Gershenwald JE et al (2006) Polymorphisms of the FAS and FAS ligand gene associated with risk of cutaneous malignant melanoma. Pharmacogenet Genomics 16:253-263
28. Zhang X, Miao X, Sun T, Tan W, Qu S, Xiong P et al (2005) Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. J Med Genet 42:479-484
29. Stuck BJ, Pani MA, Besrour F, Segni M, Krause M, Usadel KH et al (2003) Fas ligand gene polymorphisms are not associated with Hashimoto's thyroiditis and Graves' disease. Hum Immunol 64:285-289
30. Sun T, Miao X, Zhang X, Tan W, Xiong P, Lin D (2004) Polymorphisms of death pathway genesFASand FASL in esophageal squamous cell carcinoma. J Natl Cancer Inst 96:1030-1036
31. Silman AJ (1997) Problems complicating the genetic epidemiology of rheumatoid arthritis. J Rheumatol 24:194-196
32. Taneja V, Giphart MJ, Verduijn W, Naipal A, Malaviya AN, Mehra NK (1996) Polymorphism of HLA-DRB, -DQA1, and -DQB1 in rheumatoid arthritis in Asian Indians: association with DRB1*0405 and DRB1*1001. Hum Immunol 46:35-41
33. Silman AJ, MacGregor AJ, Thomson W, Holligan S, Carthy D, Farhan A, Ollier WE (1993) Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 32:903-907
34. John S, Hajeer A, Marlow A, Myerscough A, Silman AJ, Ollier WE, Worthington J (1997) Investigation of candidate disease susceptibility genes in rheumatoid arthritis: principles and strategies. J Rheumatol 24:199-201
35. Huang QR, Danis V, Lassere M, Edmonds J, Manolios N (1999) Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients. Rheumatology (Oxford) 38:645-651
36. Mohammadzadeh A, Pourfathollah AA, Tahoori MT, Daneshmandi S, Langroudi L, Akhlaghi M (2011) Evaluation of apoptosis-related gene Fas (CD95) and FasL (CD178) polymorphisms in Iranian rheumatoid arthritis patients. Rheumatol Int 31. doi: 10.1007/s00296-011-2065-x
37. Kobak S, Berdeli A (2012) Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis. Reumatismo 64:374-379